Introduction
============

Caudal block has been traditionally used for postoperative analgesia in children undergoing infraumbilical operations. In addition to its role of relieving pain after surgery, it has many advantages, including sparing effect of anesthetics and systemic opioids during general anesthesia and as an alternative to general anesthesia which is associated with potential major morbidity \[[@B1]\].

However, inaccurate procedures can lead to disastrous results through intravascular, intraosseous, and intrathecal injections, and nerve damage and block failure may also occur. Dalens et al. \[[@B2]\], reported that the success rate of caudal block at first attempt was approximately 70%. Injection related pain during caudal block may be associated with the success rate and unpredictable complications such as increase in body movement and hemodynamic instability under sedation. Eventually, additional intravenous analgesics or inhalational anesthetics under face mask ventilation are needed.

Eutectic mixture of local anesthetic (EMLA) cream is a topical anesthetic mixture of lidocaine (2.5%) and prilocaine (2.5%) in a cream base \[[@B3]\]. Given its proven efficacy and safety profile, the application of EMLA cream is recommended before vaccination of children to reduce injection related pain \[[@B4]\]. However, the benefit of EMLA cream in reducing venous puncture pain is still under debate \[[@B5]\]. Therefore, we investigated whether the EMLA cream application reduces pain response in the patients who were scheduled to undergo caudal block under sedation, and assessed the incidence of use of sevoflurane as an additional analgesic and sedative to prevent body movement during caudal block.

Materials and Methods
=====================

Study protocol
--------------

This study was approved by the institute ethics committee of our hospital and informed consent was obtained from parents before surgery. Forty-one children who were aged from 13 months to 5 years and weighed under 20 kg, had American Society of Anesthesiologists physical status 1, were undergoing infraumbilical surgery, and who were scheduled to undergo caudal block for procedures such as inguinal hernia and orchiopexy, were enrolled in this study. The patients were excluded if they had a history of allergy to local anesthetics or any components of the EMLA cream, uncertain drug sensitivities, open wound at the application site, severe systemic disease, cardiovascular disease, congenital or idiopathic methemoglobinemia and history of use of analgesics in the last 12 hours.

The patients were randomized into two groups by computer generated random numbers: 1) Placebo group 2) EMLA cream applied group. In the placebo group (Group C), the children were applied an inert placebo cream (Bepanthen®, Bayer HealthCare, Leverkusen, Germany) in the size of a coin over the sacral hiatus one hour before caudal block and the site of cream application was covered with 3M Tegaderm™ occlusive dressing by an independent anesthesiologist who was not involved in anesthesia administration or pain assessment in the operation room. In the EMLA group (Group E), EMLA cream was applied in the same manner as in the control group. The patients were sedated with intravenous ketamine 1.5 mg/kg and midazolam 0.1 mg/kg in the waiting room and were transferred after loss of response to verbal command or gentle touch was confirmed by a second anesthesiologist who assessed the pain score during the procedure. In the operation room, pulse oximetry and non-invasive blood pressure monitoring were applied. Respiratory rate and end-tidal CO~2~ were monitored via a face mask. After baseline vital signs were checked, caudal block was performed in a Sim\'s position using a 22 G needle under 50% oxygen through a face mask by one skilled anesthesiologist who was not aware of the kind of cream applied. Caudal epidural solution was prepared with 1% lidocaine and 5 µg/ml epinephrine. The solution was administered at 1 ml/kg after the confirmation of correct needle placement by aspiration.

Pain assessment was evaluated by the Multidimensional Assessment Pain Scale (MAPS) \[[@B6]\] at the following time points: T0: baseline values obtained in the operation room; T1: just before needle insertion into the sacral hiatus; T2: immediately after needle insertion into the sacral hiatus. If the needle was misplaced by movements of the patients due to pain, an assistant held the patient gently to prevent events such as injury due to fall. Five categories are included within the MAPS: vital signs (heart rate and/or blood pressure), breathing patterns, facial expression, body movements, and state of arousal ([Table 1](#T1){ref-type="table"}). Each category is graded on a three-point scale (0, 1, 2), and total scores range from 0 (no pain) to 10 (extreme pain). Then, 2--3% sevoflurane was given through a face mask when rigid and/or limited body movement occurred as the needle was advanced into the sacral hiatus because any movement affected caudal block and caused block failure. As the end-tidal concentration of sevoflurane was similar to the administered concentration, caudal block was continued. Incidence of use of sevoflurane was also assessed during caudal block. The patients maintained spontaneous ventilation with 50% oxygen via a face mask. If oxygen saturation decreased to less than 90% due to over sedation or breath holding due to procedural pain, assisted ventilation was performed. After caudal block was performed, oxygen and 1% sevoflurane were supplied via a face mask regardless of the groups to induce sedation during the operation. If analgesia was insufficient for the operation, fentanyl 0.5--1.0 µg/kg was administered. We observed the patients for any complications such as local skin reactions, toxicity of local anesthetics or anesthesia-related complications in the post anesthetic care unit (PACU) until discharge.

Statistical analysis
--------------------

Data analysis was performed using statistical software (SPSS, version 18.0 for Windows; SPSS Inc., Chicago, IL, USA). All data were expressed as the mean ± SD. Comparison between the two groups was performed using Student\'s t-test, Mann-Whitney U-test, and χ^2^-test as appropriate. Statistical significance was accepted at a P value \< 0.05. Our primary outcome was MAPS scores after the needle was advanced into the sacral hiatus. Sample size was determined based on a preliminary study. An MAPS score ≥ 4 was considered as a significant pain response caused by advancement of the needle into the sacral hiatus. Forty patients were required to show that the percentage of patients with MAPS score ≥ 4 decreased from 80% in Group C to 40% in Group E with an 80% chance of detecting significance at the 5% level. Results

Results
=======

A total of 41 children were randomly assigned to either Group C or Group E. There was no significant difference between the two groups in gender, age, weight, height, and the duration of surgery or anesthesia ([Table 2](#T2){ref-type="table"}). From T0 to T1, MAPS scores showed no difference between the two groups, but MAPS scores were significantly lower in Group E compared with Group C at T2 (P = 0.001) ([Table 3](#T3){ref-type="table"}). Furthermore, the incidence of a significant pain response (MAPS ≥ 4) when the needle was advanced into the sacral hiatus was significantly lower in Group E than in Group C (P = 0.019) ([Table 4](#T4){ref-type="table"}). At this point, the main different categories were body movement and heart rate. Especially, the incidence of rigid and/or limited body movements, which necessitated holding by the assistant along with 2--3% sevoflurane inhalation for a safe procedure, was significantly lower in Group E than in Group C (P \< 0.001) ([Table 5](#T5){ref-type="table"}). Incidence of increase in heart rate by more than 10 beats/min was significantly lower in Group E than in Group C (P = 0.018) ([Table 5](#T5){ref-type="table"}).

In Group C, frequency of use of sevoflurane was higher due to rigidity and/or limited body movements than that in Group E at T2 during caudal block (P \< 0.001) ([Table 6](#T6){ref-type="table"}). No specific complications such as breath holding or severe respiratory distress caused by pain were seen in any of the two groups during caudal block. Operation was performed successfully in all patients without additional fentanyl administration. Furthermore, in the recovery room after operation, we did not observe any complications such as seizure, cyanosis, convulsion, respiratory depression, cardiac arrhythmia caused by caudal block.

Discussion
==========

The present study confirmed that the EMLA cream was effective in reducing MAPS scores associated with caudal block and the incidence of use of sevoflurane during caudal block. A significant reduction in MAPS scores was observed in the EMLA group compared with the control group at T2. Moreover, need for sevoflurane inhalation due to rigidity and/or limited body movements was significantly lower in Group E (25%) compared with Group C (81%) at T2.

Caudal block is the most popular regional anesthetic technique in children undergoing infraumbilical surgery. Especially, it not only plays the role of anesthesia itself but also provides adjunctive postoperative analgesia. Although caudal block is partly easy and safe, block failure is the most common complication. Recently, many studies have shown that ultrasound-guided caudal block can help to improve the success rate and decrease the number of attempts \[[@B7]\]. However, skills training is necessary for the use of ultrasound in regional anesthesia, and ultrasound-guided caudal block may not feasible in all clinics due to its high cost. Sacral cornu, a landmark for caudal block, is located more superficially than in adults and sacral interspaces remain nonfused until early adulthood \[[@B8]\]. Furthermore, feeling the \'pop\' on penetrating the sacrococcygeal ligament helps to identify the caudal epidural space \[[@B9]\]. To increase the success rate and to decrease unintended complications under sedation, reduction in the injection-related pain caused by body movement and hemodynamic instability during caudal block may be of paramount importance.

EMLA cream has been widely used as a popular analgesic for pain after pediatric procedures such as venipuncture. This cream is an emulsion containing lidocaine and prilocaine, which is applied over the needle injection site, where it is absorbed into the skin. Many previous studies have shown that the EMLA cream is effective in reducing injection-related pain \[[@B10][@B11][@B12]\]. However, in contrast to these studies, some studies showed that EMLA cream applied on the venous puncture site, did not decrease the pain score significantly compared with the oral glucose group or placebo group \[[@B5][@B13]\]. In this study, the application of EMLA cream over the sacral hiatus before caudal anesthesia decreased the MAPS scores reflecting injection-related pain. In body movements, as one of the MAPS categories, rigid and/or limited body movements were significantly less in Group E compared with Group C ([Table 5](#T5){ref-type="table"}) and this consequently resulted in reduction in requirement of additional sevoflurane inhalation via a mask compared with that in Group C ([Table 6](#T6){ref-type="table"}). The intensity of restless body movement was weak. Therefore, it did not cause disturbance during the procedure and sevoflurane inhalation was needed. Furthermore, EMLA cream application effectively prevented the increase in heart rate during the procedure ([Table 5](#T5){ref-type="table"}). Caudal block did not cause a decrease in the heart rate in any cases of our study.

Despite the effectiveness of EMLA cream, a relatively long time to peak effect for adequate anesthesia may be impractical and inconvenient in many clinical situations. Generally, the application time recommended by manufacturers is about 60 minutes \[[@B14]\]. However, Hopkins et al. \[[@B15]\] showed that there is no correlation between efficacy and application time after 30 minutes of application. It can be suggested that further studies regarding shorter application time should be performed to establish the effectiveness of the cream. Besides the discomfort related to the application time, local skin reactions such as erythema, pallor, and itching may follow EMLA cream application \[[@B16]\]. However, we did not observe any adverse effects in the operation room and PACU.

Combined with caudal block, methods for maintaining airway patency included use of a laryngeal mask, face mask, and tracheal intubation. On comparison of different airway management techniques, the complication rate was the lowest in the face mask group \[[@B17]\]. In addition, face mask ventilation caused lower airway irritation compared with tracheal intubation \[[@B18]\]. Therefore, face mask sedation combined with caudal block is suggested as another option for pediatric patients undergoing infraumbilical surgery. Ketamine 1.5 mg/kg reduces the additional requirement for analgesia below 10% during pediatric procedures compared with 1.0 mg/kg in cases of laceration repair, incision and drainage, etc. \[[@B19]\]. But in this study, ketamine 1.5 mg/kg provided inadequate analgesia and frequent sevoflurane inhalation was required in patients of Group C (81%). In pediatric sedation, there was an association between adverse outcomes and administration of number of sedative agents. Three or more agents used for sedation showed higher association with adverse outcomes. Furthermore, drug combination and interaction contributed to negative outcomes \[[@B20]\]. Only 1.8--2.0% sevoflurane sedation in pediatric patients on MRI was usually successful but hypoxia occurred in few cases \[[@B21]\]. In our experience from this study, 2--3% sevoflurane via a face mask was required for prevention of rigid and/or limited body movements in the control group and 1% sevoflurane via a face mask was enough to achieve sedation during operation after caudal block in both groups. Furthermore, pediatric patients were sedated with ketamine and midazolam in the waiting room and sevoflurane was used as an additive if we needed more sedation during caudal block. Therefore, EMLA application over the sacral hiatus before caudal block reduces the number of drugs used for sedation during caudal block and may contribute to reducing adverse outcomes by less usage of sevoflurane during caudal block.

The limitation of this study was that we did not assess the extent to which EMLA cream affected lidocaine concentration in caudal block. We just applied EMLA cream over the sacral hiatus in the size of a coin and used 1% lidocaine in the same dose for caudal anesthesia during infraumbilical surgery in our hospital previously.

In conclusion, this investigation showed that children receiving pre-treatment with EMLA cream before caudal block showed significantly lower MAPS scores and incidence of use of sevoflurane compared with the placebo group immediately after needle insertion. Therefore, we suggest that the use of EMLA cream before caudal block has significant advantages in alleviating procedure pain during caudal block.

###### The Multidimensional Assessment Pain Scale

![](kjae-69-149-i001)

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Categories                         0                                      1                                                                         2
  ---------------------------------- -------------------------------------- ------------------------------------------------------------------------- -------------------------------------------------------------------------
  Vital signs\                       Within baseline                        Increase of more than 10 beats/min and/or increase of more than 10 mmHg   Decrease of more than 10 beats/min and/or decrease of more than 10 mmHg
  Heart rate and/or Blood pressure                                                                                                                    

  Breathing pattern                  No change                              Development or increase in respiratory distress                           Severe respiratory distress

  Facial expressions                 Relaxed                                Grimace                                                                   Grimace associated with silent or weak cry

  Body movements                     No movements or purposeful movements   Restless                                                                  Rigid and/or limited body movements

  State of arousal                   Calm or asleep                         Hyperreactive                                                             Shut down
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### Patient Demographic Data
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  ------------------------------------------------------------------------
                                 Group C\      Group E\      P value^\*^
                                 (n = 21)      (n = 20)      
  ------------------------------ ------------- ------------- -------------
  Male/female (n)                16/5          17/3          NS

  Age (months)                   35.2 ± 15.6   33.0 ± 13.1   NS

  Height (cm)                    96.2 ± 8.4    92.5 ± 10.8   NS

  Weight (kg)                    14.5 ± 2.8    13.6 ± 2.9    NS

  Duration of surgery (min)      30.6 ± 9.8    32.4 ± 8.7    NS

  Duration of anesthesia (min)   49.8 ± 12.7   48.7 ± 10.4   NS
  ------------------------------------------------------------------------

Data are presented as number or mean ± SD. Group C: Placebo group, Group E: EMLA group, NS: no significant differences. ^\*^Student\'s t-test or χ^2^-test as appropriate.

###### Comparison of the Multidimensional Assessment Pain Scale
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       Group C (n = 21)   Group E (n = 20)   P value^\*^
  ---- ------------------ ------------------ -------------
  T0   2.0                2.0                NS
  T1   2.1 ± 0.4          2.1 ± 0.2          NS
  T2   4.5 ± 1.0          3.3 ± 1.0          0.001

Data are presented as Mean ± SD. Group C: Placebo group, Group E: EMLA group, T0: baseline values, T1: before needle insertion, T2: after needle insertion, NS: no significant differences. ^\*^Mann-Whitney U test was used for the comparison of MAPS score.

###### Incidence of Significant Pain Response Caused by Advancement of the Needle Into the Sacral Hiatus at T2
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              Group C (n = 21)   Group E (n = 20)
  ----------- ------------------ ------------------
  MAPS \< 4   6 (29)             13 (65)
  MAPS ≥ 4    15 (71)            7 (35)^\*^

Data are presented as number of patients (%). Group C: Placebo group, Group E: EMLA group, MAPS: Multidimensional Assessment Pain Scale, MAPS ≥ 4 was considered as a significant pain response caused by advancement of the needle into the sacral hiatus. ^\*^Incidence of significant pain response caused by advancement of the needle into the sacral hiatus was significantly lower in Group E than in Group C (P \< 0.05) by χ^2^-test.

###### Incidence of Mainly Showing Difference in Category at T2
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                     Incidence of increase in heart rate by more than 10 beats/min   Body movements   
  ------------------ --------------------------------------------------------------- ---------------- -----------
  Group E (n = 20)   3 (15)^\*^                                                      9 (45)           5 (25)^†^
  Group C (n = 21)   10 (48)                                                         4 (19)           17 (81)

Data are presented as number of patients (%). Group C: Placebo group, Group E: EMLA group. ^\*^Incidence of increase in heart rate by more than 10 beats/min was significantly lower in Group E than in Group C (P \< 0.05) by χ^2^-test. ^†^Rigid and/or limited body movements showed a significantly lower incidence in Group E compared with Group C (P \< 0.01) by χ^2^-test.

###### Incidence of Use of Sevoflurane during Caudal Block

![](kjae-69-149-i006)

       Group C (n = 21)   Group E (n = 20)   P value^\*^
  ---- ------------------ ------------------ -------------
  T0   0 (0)              0 (0)              NS
  T1   1 (4.8)            0 (0)              NS
  T2   17 (81)            5 (25)             \< 0.001

Data are presented as number of patients (%). Group C: Placebo group, Group E: EMLA group, T0: baseline values; T1: before needle insertion; T2: after needle insertion, NS: no significant differences. ^\*^χ^2^-test was used to compare the incidence of use of sevoflurane between the two groups.
